News

Plenary Line-Up Announced for the 9th IAS Conference on HIV Science (IAS 2017)

posted on

17 January 2017 (Geneva, Switzerland) – Today, the International AIDS Society (IAS) announced the plenary speakers and programme for the 9th IAS Conference on HIV Science (IAS 2017). Hosted in partnership with ANRS (The French National Agency for Research on AIDS and Viral Hepatitis), the conference will take place from 23-26 July 2017 in Paris, France.

“We’re at a critical juncture in HIV research. Despite the remarkable scientific progress made, there are many roadblocks slowing its implementation,” said Linda-Gail Bekker, IAS 2017 International Chair and IAS President. “Now is the time for science to drive our progress forward. At IAS 2017, high-priority research areas and novel interventions in the HIV response will take centre stage led by our diverse and international plenary line-up.” 

The plenary programme will feature sessions that cover innovative prevention, treatment, and care approaches for HIV. The speakers will spotlight the latest developments in vaccines, cure research for hepatitis B, cancer and immune-based therapies, as well as providing new insights into improved preventative and therapeutic measures.

“IAS 2017 will be an agenda-setting meeting for the global response to HIV,” said Jean-François Delfraissy, IAS 2017 Local Chair and Director of ANRS. “This year’s plenary programme features another outstanding, curated line-up of the world’s leading HIV experts. We are privileged to have them join us in Paris which will be the capital of HIV and AIDS research in 2017.”

The programme for IAS 2017 is under development and will be available on the conference website www.ias2017.org in the coming months. Registration to attend the conference is open and more information is available at www.ias2017.org/Register-for-the-conference

 

IAS 2017 Plenary Programme

Please note that presentation titles and the programme are subject to change: 

Monday, 24 July 2017

  • Harnessing the Immune System to Prevent and Control HIV Infection
    Yves Lévy, France
  • Meeting the Needs of People Living with HIV: The Top Priority for Programmes
    Wafaa El-Sadr, United States
  • Adding D to the ABC: Putting the Drugs in the ABC of Prevention
    Sheena McCormack, United Kingdom

Tuesday, 25 July 2017

  • HIV Restriction Factors: From Bench to Bedside
    Paul Bieniasz, United States
  • Economic Incentives for HIV Prevention in Latin America
    Sandra G. Sosa-Rubí, Mexico
  • What Will It Take to End Paediatric HIV: The Emergency Plan
    Nadia Sam-Agudu, Nigeria

Wednesday, 26 July 2017

  • PD-1 Blockade Immunotherapy Against Cancer and Infectious Diseases
    Tasuku Honjo, Japan
  • Antiretroviral Therapy and Beyond
    Alexandra Calmy, Switzerland
  • Challenges and Novel Approaches to Cure HBV Infection
    Fabien Zoulim, France

###

About the International AIDS Society (IAS)
Founded in 1988, the IAS is the world’s largest association of HIV professionals, with members from more than 180 countries working on all fronts of the global AIDS response. Together, we advocate and drive urgent action to reduce the global impact of HIV. For more information visit: www.iasociety.org

About the IAS Conference on HIV Science (IAS 2017)
The IAS Conference on HIV Science is the largest open scientific conference on HIV and AIDS related issues. The 9th IAS Conference on HIV Science (IAS 2017) will take place on 23-26 July 2017 at the Palais des Congrès in Paris, France. More than 6,000 professionals from around the world will convene at IAS 2017 to examine the latest scientific developments in HIV-related research with a focus on moving science into practice and policy. IAS 2017 is organized by the International AIDS Society (IAS) in partnership with ANRS (The French National Agency for Research on AIDS and Viral Hepatitis). For more information visit: www.ias2017.org

Contact:
Mandy Sugrue
Senior Manager, Communications, IAS
[email protected]
+41 22 710 08 43

 

| Return